Search research articles
Contact Us
Filters
Showing results (81-90 of 112) with videos related to
Page
of 12
Sort By:
Blood Cells, Molecules & Diseases
|
July 22, 2020
Investigating the clinical, hematological and cytogenetic profile of endoreduplicated hypodiploids in BCP-ALL
Dhanlaxmi Shetty, Pratibha Kadam Amare, Purvi Mohanty, et al.
International Journal of Laboratory Hematology
|
January 12, 2021
Expression of CD304/neuropilin-1 in adult b-cell lymphoblastic leukemia/lymphoma and its utility for the measurable residual disease assessment
Gaurav Chatterjee, Vishesh Dudakia, Sitaram Ghogale, et al.
The Lancet. Haematology
|
April 1, 2016
HLA match likelihoods for Indian patients seeking unrelated donor transplantation grafts: a population-based study
Martin Maiers, Michael Halagan, Sangeeta Joshi, et al.
Cytometry. Part B, Clinical Cytometry
|
November 8, 2022
Expression levels and patterns of B-cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent
Harshini Sriram, Florence Kunjachan, Twinkle Khanka, et al.
Cytotherapy
|
February 4, 2025
A comparison of mobilization regimens used in Hodgkin lymphoma and factors that influence peripheral blood stem cell mobilization
Anant Gokarn, Laxma Reddy, Sumathi Hiregoudar, et al.
Ejhaem
|
December 12, 2025
Multiple Myeloma in Young Adults-Insights From a Tertiary Care Cancer Centre in India
George John, Sumeet Mirgh, Sachin Punatar, et al.
Indian Journal of Pathology & Microbiology
|
March 24, 2018
Applicability of 2008 World Health Organization classification system of hematolymphoid neoplasms: Learning experiences
Sushil Modkharkar, Pooja Navale, Pratibha Kadam Amare, et al.
Cancer Immunology, Immunotherapy : CII
|
February 23, 2026
Defining alteration in bone marrow mesenchymal stem cells (MSC) from acute myeloid leukemia and exploring cultured MSC-conditioned media as a novel anti-leukemia therapy agent
Manasi Nagare, Monalisa Sahoo, Manju Sengar, et al.
Leukemia & Lymphoma
|
March 22, 2016
Characteristics of BCR-ABL kinase domain mutations in chronic myeloid leukemia from India: not just missense mutations but insertions and deletions are also associated with TKI resistance
Nikhil Patkar, Kiran Ghodke, Swapnali Joshi, et al.
Oncotarget
|
December 20, 2018
Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in <i>NPM1</i> mutated acute myeloid leukemia
Nikhil Patkar, Rohan Kodgule, Chinmayee Kakirde, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 112) with videos related to
Sort By:
Page
of 12
Blood Cells, Molecules & Diseases
|
July 22, 2020
Investigating the clinical, hematological and cytogenetic profile of endoreduplicated hypodiploids in BCP-ALL
Dhanlaxmi Shetty, Pratibha Kadam Amare, Purvi Mohanty, et al.
International Journal of Laboratory Hematology
|
January 12, 2021
Expression of CD304/neuropilin-1 in adult b-cell lymphoblastic leukemia/lymphoma and its utility for the measurable residual disease assessment
Gaurav Chatterjee, Vishesh Dudakia, Sitaram Ghogale, et al.
The Lancet. Haematology
|
April 1, 2016
HLA match likelihoods for Indian patients seeking unrelated donor transplantation grafts: a population-based study
Martin Maiers, Michael Halagan, Sangeeta Joshi, et al.
Cytometry. Part B, Clinical Cytometry
|
November 8, 2022
Expression levels and patterns of B-cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent
Harshini Sriram, Florence Kunjachan, Twinkle Khanka, et al.
Cytotherapy
|
February 4, 2025
A comparison of mobilization regimens used in Hodgkin lymphoma and factors that influence peripheral blood stem cell mobilization
Anant Gokarn, Laxma Reddy, Sumathi Hiregoudar, et al.
Ejhaem
|
December 12, 2025
Multiple Myeloma in Young Adults-Insights From a Tertiary Care Cancer Centre in India
George John, Sumeet Mirgh, Sachin Punatar, et al.
Indian Journal of Pathology & Microbiology
|
March 24, 2018
Applicability of 2008 World Health Organization classification system of hematolymphoid neoplasms: Learning experiences
Sushil Modkharkar, Pooja Navale, Pratibha Kadam Amare, et al.
Cancer Immunology, Immunotherapy : CII
|
February 23, 2026
Defining alteration in bone marrow mesenchymal stem cells (MSC) from acute myeloid leukemia and exploring cultured MSC-conditioned media as a novel anti-leukemia therapy agent
Manasi Nagare, Monalisa Sahoo, Manju Sengar, et al.
Leukemia & Lymphoma
|
March 22, 2016
Characteristics of BCR-ABL kinase domain mutations in chronic myeloid leukemia from India: not just missense mutations but insertions and deletions are also associated with TKI resistance
Nikhil Patkar, Kiran Ghodke, Swapnali Joshi, et al.
Oncotarget
|
December 20, 2018
Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in <i>NPM1</i> mutated acute myeloid leukemia
Nikhil Patkar, Rohan Kodgule, Chinmayee Kakirde, et al.
Page
of 12